Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up
Open Access
- 3 December 2010
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 270 (1), 65-75
- https://doi.org/10.1111/j.1365-2796.2010.02333.x
Abstract
Langsted A, Freiberg JJ, Tybjærg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG (Herlev Hospital, Herlev; University of Copenhagen; Bispebjerg Hospital; and Rigshospitalet, Copenhagen Ø, Denmark). Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up. J Intern Med 2011; 270: 65–75. Objectives. We compared the ability of very high levels of nonfasting cholesterol and triglycerides to predict risk of myocardial infarction and total mortality. Design. Prospective study from 1976 to 1978 until 2007. Setting. Danish general population. Participants. Randomly selected population of 7581 women and 6391 men, of whom 768 and 1151 developed myocardial infarction and 4398 and 4416 died, respectively. Participation rate was 72%, and follow-up was 100% complete. Less than 2% of participants were taking lipid-lowering therapy. Results. Compared to women with cholesterol −1, multivariate-adjusted hazard ratios for myocardial infarction ranged from 1.3 [95% confidence interval (CI): 0.9–1.8] for a cholesterol level of 5.0–5.99 mmol L−1 to 2.5 (95%CI: 1.6–4.0) for cholesterol ≥9 mmol L−1 (trend: P < 0.0001). Compared with women with nonfasting triglycerides −1, hazard ratios for myocardial infarction ranged from 1.5 (95%CI: 1.2–1.8) for triglycerides of 1.0–1.99 mmol L−1 to 4.2 (95%CI: 2.5–7.2) for triglycerides ≥5 mmol L−1 (pP < 0.0001) and from 1.3 (95%CI: 1.0–1.6) to 2.1 (95%CI: 1.5–2.8) for triglycerides (P < 0.0001). Increasing cholesterol levels were not consistently associated with total mortality in women (trend: P = 0.39) or men (P = 0.02). By contrast, compared with women with triglycerides −1, multivariate-adjusted hazard ratios for total mortality ranged from 1.1 (95%CI: 1.0–1.2) for triglycerides of 1.0–1.99 mmol L−1 to 2.0 (95%CI: 1.5–2.9) for triglycerides ≥5 mmol L−1 (trend: P < 0.0001); corresponding hazard ratios in men ranged from 1.1 (95%CI: 1.0–1.2) to 1.5 (95%CI: 1.2–1.7) (P < 0.0001). Conclusions. Stepwise increasing levels of nonfasting cholesterol and nonfasting triglycerides were similarly associated with stepwise increasing risk of myocardial infarction, with nonfasting triglycerides being the best predictor in women and nonfasting cholesterol the best predictor in men. Even more surprisingly, only increasing levels of nonfasting triglycerides were associated with total mortality, whereas increasing cholesterol levels were not.Keywords
This publication has 22 references indexed in Scilit:
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent CardioprotectionScience, 2008
- Nonfasting Triglycerides and Risk of Ischemic Stroke in the General PopulationJAMA, 2008
- European guidelines on cardiovascular disease prevention in clinical practice: Executive summaryAtherosclerosis, 2007
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Cardiovascular Disease Mortality in Familial Forms of Hypertriglyceridemia: A 20-Year Prospective StudyCirculation, 2000
- Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective StudiesAmerican Journal of Epidemiology, 1999
- The recognition and management of hyperlipidaemia in adults: A policy statement of the EuropeanEuropean Heart Journal, 1988